Figure 1

Asthma-related resource use and asthma attacks according to the presence of concomitant allergic rhinitis. In a post-hoc analysis of the Investigation of Montelukast as a Partner Agent for Complementary Therapy trial, rates of asthma attacks and emergency room visits were significantly higher among patients with comorbid asthma and allergic rhinitis (AR). Adapted with permission from Bousquet and coworkers [34].